Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Clozapine | 2 | 2020 | 4 | 1.400 |
Why?
|
| Prefrontal Cortex | 3 | 2020 | 69 | 1.210 |
Why?
|
| Anesthesia Recovery Period | 1 | 2022 | 3 | 0.850 |
Why?
|
| Acetylcholine | 2 | 2012 | 47 | 0.840 |
Why?
|
| Anesthesia, General | 1 | 2022 | 29 | 0.830 |
Why?
|
| Anesthetics, Inhalation | 2 | 2022 | 17 | 0.830 |
Why?
|
| Macaca mulatta | 6 | 2020 | 322 | 0.800 |
Why?
|
| Recovery of Function | 1 | 2022 | 190 | 0.770 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 379 | 0.760 |
Why?
|
| Designer Drugs | 1 | 2020 | 1 | 0.750 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 29 | 0.720 |
Why?
|
| Amnesia, Retrograde | 1 | 2018 | 1 | 0.670 |
Why?
|
| Mental Recall | 1 | 2018 | 52 | 0.650 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 89 | 0.630 |
Why?
|
| Cognition | 1 | 2022 | 526 | 0.620 |
Why?
|
| Learning | 1 | 2018 | 76 | 0.620 |
Why?
|
| Memory Disorders | 1 | 2017 | 61 | 0.590 |
Why?
|
| Hippocampus | 1 | 2018 | 185 | 0.580 |
Why?
|
| Memory, Short-Term | 2 | 2020 | 59 | 0.580 |
Why?
|
| Visual Perception | 1 | 2017 | 112 | 0.560 |
Why?
|
| Memory | 1 | 2017 | 187 | 0.540 |
Why?
|
| Neurons | 1 | 2018 | 394 | 0.510 |
Why?
|
| Brain Damage, Chronic | 1 | 2012 | 3 | 0.450 |
Why?
|
| Cholinergic Fibers | 1 | 2012 | 7 | 0.440 |
Why?
|
| Amnesia | 1 | 2012 | 10 | 0.440 |
Why?
|
| Fornix, Brain | 1 | 2012 | 7 | 0.440 |
Why?
|
| Temporal Lobe | 1 | 2012 | 41 | 0.430 |
Why?
|
| Animals | 6 | 2020 | 7302 | 0.380 |
Why?
|
| Reward | 3 | 2018 | 63 | 0.360 |
Why?
|
| Decision Making | 1 | 2011 | 180 | 0.350 |
Why?
|
| Male | 6 | 2022 | 17876 | 0.290 |
Why?
|
| Propofol | 1 | 2022 | 19 | 0.210 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 981 | 0.200 |
Why?
|
| Female | 4 | 2022 | 18241 | 0.190 |
Why?
|
| N-Methylaspartate | 1 | 2018 | 12 | 0.170 |
Why?
|
| Age Factors | 1 | 2022 | 1110 | 0.160 |
Why?
|
| Transduction, Genetic | 1 | 2018 | 42 | 0.160 |
Why?
|
| Genetic Vectors | 1 | 2018 | 118 | 0.160 |
Why?
|
| Reaction Time | 1 | 2018 | 121 | 0.160 |
Why?
|
| Animals, Newborn | 1 | 2017 | 111 | 0.150 |
Why?
|
| Aged, 80 and over | 1 | 2022 | 3728 | 0.120 |
Why?
|
| Pattern Recognition, Visual | 1 | 2012 | 12 | 0.110 |
Why?
|
| Psychomotor Performance | 1 | 2012 | 97 | 0.100 |
Why?
|
| Parvalbumins | 1 | 2011 | 6 | 0.100 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 1 | 2011 | 6 | 0.100 |
Why?
|
| Acetylcholinesterase | 1 | 2011 | 17 | 0.100 |
Why?
|
| Immunotoxins | 1 | 2011 | 16 | 0.100 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2011 | 22 | 0.100 |
Why?
|
| Space Perception | 1 | 2011 | 26 | 0.100 |
Why?
|
| Neuronal Plasticity | 1 | 2012 | 81 | 0.100 |
Why?
|
| Random Allocation | 1 | 2011 | 213 | 0.100 |
Why?
|
| Macaca fascicularis | 1 | 2012 | 389 | 0.100 |
Why?
|
| Photic Stimulation | 1 | 2011 | 155 | 0.100 |
Why?
|
| Conditioning, Operant | 1 | 2011 | 96 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2011 | 454 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 196 | 0.090 |
Why?
|
| Adult | 1 | 2022 | 8468 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2012 | 312 | 0.080 |
Why?
|
| Aged | 1 | 2022 | 9515 | 0.080 |
Why?
|
| Middle Aged | 1 | 2022 | 10872 | 0.080 |
Why?
|
| Humans | 1 | 2022 | 29220 | 0.050 |
Why?
|